359 related articles for article (PubMed ID: 24625017)
1. Response to lithium in bipolar disorder: clinical and genetic findings.
Rybakowski JK
ACS Chem Neurosci; 2014 Jun; 5(6):413-21. PubMed ID: 24625017
[TBL] [Abstract][Full Text] [Related]
2. Genetic influences on response to mood stabilizers in bipolar disorder: current status of knowledge.
Rybakowski JK
CNS Drugs; 2013 Mar; 27(3):165-73. PubMed ID: 23378337
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with lithium efficacy in bipolar disorder.
Rybakowski JK
Harv Rev Psychiatry; 2014; 22(6):353-7. PubMed ID: 25377609
[TBL] [Abstract][Full Text] [Related]
4. The Pharmacogenomics of Bipolar Disorder study (PGBD): identification of genes for lithium response in a prospective sample.
Oedegaard KJ; Alda M; Anand A; Andreassen OA; Balaraman Y; Berrettini WH; Bhattacharjee A; Brennand KJ; Burdick KE; Calabrese JR; Calkin CV; Claasen A; Coryell WH; Craig D; DeModena A; Frye M; Gage FH; Gao K; Garnham J; Gershon E; Jakobsen P; Leckband SG; McCarthy MJ; McInnis MG; Maihofer AX; Mertens J; Morken G; Nievergelt CM; Nurnberger J; Pham S; Schoeyen H; Shekhtman T; Shilling PD; Szelinger S; Tarwater B; Yao J; Zandi PP; Kelsoe JR
BMC Psychiatry; 2016 May; 16():129. PubMed ID: 27150464
[TBL] [Abstract][Full Text] [Related]
5. Neurobiology and temperament in the offspring of excellent lithium responders.
Ferensztajn E; Skibinska M; Kaczmarek M; Losy J; Rybakowski JK
World J Biol Psychiatry; 2015 Jun; 16(4):272-7. PubMed ID: 24824424
[TBL] [Abstract][Full Text] [Related]
6. Association study of
Paul P; Nadella RK; Sen S; Ithal D; Mahadevan J; Reddy Y C J; Jain S; Purushottam M; Viswanath B
J Psychopharmacol; 2021 Dec; 35(12):1510-1516. PubMed ID: 34311608
[TBL] [Abstract][Full Text] [Related]
7. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
8. The International Consortium on Lithium Genetics (ConLiGen): an initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatment.
Schulze TG; Alda M; Adli M; Akula N; Ardau R; Bui ET; Chillotti C; Cichon S; Czerski P; Del Zompo M; Detera-Wadleigh SD; Grof P; Gruber O; Hashimoto R; Hauser J; Hoban R; Iwata N; Kassem L; Kato T; Kittel-Schneider S; Kliwicki S; Kelsoe JR; Kusumi I; Laje G; Leckband SG; Manchia M; Macqueen G; Masui T; Ozaki N; Perlis RH; Pfennig A; Piccardi P; Richardson S; Rouleau G; Reif A; Rybakowski JK; Sasse J; Schumacher J; Severino G; Smoller JW; Squassina A; Turecki G; Young LT; Yoshikawa T; Bauer M; McMahon FJ
Neuropsychobiology; 2010; 62(1):72-8. PubMed ID: 20453537
[TBL] [Abstract][Full Text] [Related]
9. Evidence for association of an ACCN1 gene variant with response to lithium treatment in Sardinian patients with bipolar disorder.
Squassina A; Manchia M; Borg J; Congiu D; Costa M; Georgitsi M; Chillotti C; Ardau R; Mitropoulos K; Severino G; Del Zompo M; Patrinos GP
Pharmacogenomics; 2011 Nov; 12(11):1559-69. PubMed ID: 21961650
[TBL] [Abstract][Full Text] [Related]
10. Lithium response in bipolar disorder: Genetics, genomics, and beyond.
Papiol S; Schulze TG; Heilbronner U
Neurosci Lett; 2022 Aug; 785():136786. PubMed ID: 35817312
[TBL] [Abstract][Full Text] [Related]
11. Psychiatric and physical outcomes of long-term use of lithium in older adults with bipolar disorder and major depressive disorder: A cross-sectional multicenter study.
Morlet E; Costemale-Lacoste JF; Poulet E; McMahon K; Hoertel N; Limosin F;
J Affect Disord; 2019 Dec; 259():210-217. PubMed ID: 31446382
[TBL] [Abstract][Full Text] [Related]
12. Alterations in BDNF (brain derived neurotrophic factor) and GDNF (glial cell line-derived neurotrophic factor) serum levels in bipolar disorder: The role of lithium.
Tunca Z; Ozerdem A; Ceylan D; Yalçın Y; Can G; Resmi H; Akan P; Ergör G; Aydemir O; Cengisiz C; Kerim D
J Affect Disord; 2014 Sep; 166():193-200. PubMed ID: 25012431
[TBL] [Abstract][Full Text] [Related]
13. Lithium-responsive genes and gene networks in bipolar disorder patient-derived lymphoblastoid cell lines.
Breen MS; White CH; Shekhtman T; Lin K; Looney D; Woelk CH; Kelsoe JR
Pharmacogenomics J; 2016 Oct; 16(5):446-53. PubMed ID: 27401222
[TBL] [Abstract][Full Text] [Related]
14. Safety and effectiveness of continuation antidepressant versus mood stabilizer monotherapy for relapse-prevention of bipolar II depression: A randomized, double-blind, parallel-group, prospective study.
Amsterdam JD; Lorenzo-Luaces L; Soeller I; Li SQ; Mao JJ; DeRubeis RJ
J Affect Disord; 2015 Oct; 185():31-7. PubMed ID: 26143402
[TBL] [Abstract][Full Text] [Related]
15. The Role of Pharmacogenomics in Bipolar Disorder: Moving Towards Precision Medicine.
Pisanu C; Heilbronner U; Squassina A
Mol Diagn Ther; 2018 Aug; 22(4):409-420. PubMed ID: 29790107
[TBL] [Abstract][Full Text] [Related]
16. Lithium, Stress, and Resilience in Bipolar Disorder: Deciphering this key homeostatic synaptic plasticity regulator.
Machado-Vieira R
J Affect Disord; 2018 Jun; 233():92-99. PubMed ID: 29310970
[TBL] [Abstract][Full Text] [Related]
17. The pharmacogenetics of lithium response depends upon clinical co-morbidity.
Bremer T; Diamond C; McKinney R; Shehktman T; Barrett TB; Herold C; Kelsoe JR
Mol Diagn Ther; 2007; 11(3):161-70. PubMed ID: 17570738
[TBL] [Abstract][Full Text] [Related]
18. Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study.
Hou L; Heilbronner U; Degenhardt F; Adli M; Akiyama K; Akula N; Ardau R; Arias B; Backlund L; Banzato CEM; Benabarre A; Bengesser S; Bhattacharjee AK; Biernacka JM; Birner A; Brichant-Petitjean C; Bui ET; Cervantes P; Chen GB; Chen HC; Chillotti C; Cichon S; Clark SR; Colom F; Cousins DA; Cruceanu C; Czerski PM; Dantas CR; Dayer A; Étain B; Falkai P; Forstner AJ; Frisén L; Fullerton JM; Gard S; Garnham JS; Goes FS; Grof P; Gruber O; Hashimoto R; Hauser J; Herms S; Hoffmann P; Hofmann A; Jamain S; Jiménez E; Kahn JP; Kassem L; Kittel-Schneider S; Kliwicki S; König B; Kusumi I; Lackner N; Laje G; Landén M; Lavebratt C; Leboyer M; Leckband SG; Jaramillo CAL; MacQueen G; Manchia M; Martinsson L; Mattheisen M; McCarthy MJ; McElroy SL; Mitjans M; Mondimore FM; Monteleone P; Nievergelt CM; Nöthen MM; Ösby U; Ozaki N; Perlis RH; Pfennig A; Reich-Erkelenz D; Rouleau GA; Schofield PR; Schubert KO; Schweizer BW; Seemüller F; Severino G; Shekhtman T; Shilling PD; Shimoda K; Simhandl C; Slaney CM; Smoller JW; Squassina A; Stamm T; Stopkova P; Tighe SK; Tortorella A; Turecki G; Volkert J; Witt S; Wright A; Young LT; Zandi PP; Potash JB; DePaulo JR; Bauer M; Reininghaus EZ; Novák T; Aubry JM; Maj M; Baune BT; Mitchell PB; Vieta E; Frye MA; Rybakowski JK; Kuo PH; Kato T; Grigoroiu-Serbanescu M; Reif A; Del Zompo M; Bellivier F; Schalling M; Wray NR; Kelsoe JR; Alda M; Rietschel M; McMahon FJ; Schulze TG
Lancet; 2016 Mar; 387(10023):1085-1093. PubMed ID: 26806518
[TBL] [Abstract][Full Text] [Related]
19. Lithium treatment - the state of the art for 2020.
Rybakowski J
Psychiatr Pol; 2020 Dec; 54(6):1047-1066. PubMed ID: 33740796
[TBL] [Abstract][Full Text] [Related]
20. [Predictors of prophylactic response to lithium].
Rohayem J; Baylé JF; Richa S
Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
